People

All our partners are very experienced in their respective expertise areas and collectively bring an unparalleled capability to bear on Client problems of expertise and/or capacity. TranScrip Partners will continue to grow its expert base as new Senior Partners, Partners and Associates join.

View the tables below to see our Partners, Academic Advisors, Management and Board Members (click on the name of a person to see their full bio):

  • Partners
    Name Competencies & Expert Areas
    Richard Bax
    Senior Partner    		 Drug development of anti-infectives, including antibiotics, antivirals, antifungals and vaccines
    Chris Blakeley
    Senior Partner    		 Drug development across several therapeutic areas, especially oncology, urology and respiratory
    Paul Branthwaite
    Senior Partner    		 Business development and marketing
    Carol Burley
    Partner    		 Clinical development, project management, medical writing
    Sarah Daniels
    Senior Partner    		 Pharmacovigilance (EU QPPV), drug development and medical affairs in virology, oncology and CNS
    Flic Gabbay
    Senior Partner    		 Drug development, several therapeutic areas especially anti-infectives, respiratory. Pre-registration pharmacovigilance and Special interest in Education
    Colin Knight
    Partner    		 Pharmacovigilance, medical information, medical writing
    Marcin Mankowski
    Senior Partner    		 Drug development and medical affairs, especially in anti-infectives, including antibiotics, antifungals and antivirals
    Ursula Mason
    Senior Partner    		 Drug discovery, development programme design & leadership, CNS & immuno-inflammatory diseases. Biotechnology products, GCP and SOP audits, regulatory Inspection readiness preparation audits, development of Quality Assurance approaches. rigorous Quality Control.
    Alex Meldrum
    Partner    		 Regulatory affairs across different therapeutic areas
    N Sreeharan
    Senior Partner    		 Drug development and medical affairs in multiple therapeutic areas. Special interest in Governance and Education
    Dave Griffin
    Partner    		 Microbiology
    Andy Blackman
    Partner    		 Drug safety
  • Academic advisors
    AdvisorsCompetencies and Expert Area
    David Goldsmith
    Senior Partner    		 Academic advisor in nephrology, transplantation and toxicology
    Karol Sikora
    Senior Partner    		 Academic advisor in oncology
  • Management
    NameCompetencies and Expert Area
    Flic Gabbay
    Managing Partner    		 Flic Gabbay is a pharmaceutical physician with over 25 years of industry experience, including as Global Head of Anti-infectives, at Parke Davis in the US. She has worked for pharma and bio-tech companies in Europe and North America. Flic is a co-founder of TranScrip Partners and is the Managing Partner.
    Marcin Mankowski
    Operating Partner    		 Marcin Mankowski is a pharmaceutical physician with 14 years experience in clinical development and medical affairs. Marcin worked for Bristol-Myers Squibb and later at Chiron Pharmaceuticals, where he was Head of Infectious Diseases in Europe. Marcin is a co-founder of TranScrip Partners and is responsible for operational matters.
    Paul Branthwaite
    Business Development    		 A pharmacologist by training, Paul has operational and managerial experience within clinical development and medical affairs, including leading business development efforts and global clinical programmes for two CROs, and UK clinical operations for a Swedish biotech. Paul is responsible for Business Development and Marketing activities at TranScrip.
    N Sreeharan
    Corporate Governance    		 Dr Sreeharan (Sree) is a pharmaceutical physician with over 20 years industry experience. Before joining TranScrip Partners, Sree worked over 20 years at GlaxoSmithKline, where he held several positions including that of Senior Vice President in the global R&D organization spanning over 20 years. As part of the Management Team Sree is responsible for continuing professional development, quality and corporate governance.
    William Plant
    Finance Director    		 William Plant has held a variety of senior Finance Director roles at both local and European levels. His corporate career includes CA, Oracle Corporation, Kingfisher PLC and Data General. William qualified as a chartered accountant from PwC and has an MA from Cambridge in Natural Sciences and Management Studies.
  • Board Members
    NameCompetencies and Expert Area
    David Oxlade
    Non-Executive Chairman    		 David is a pharmaceutical professional with extensive experience in the global health care industry, having worked at senior management and Board level for 6 years in the USA and 7 years in Asia. Previously CEO of Xenova (the LSE and NASDAQ listed biotech), in 2006 he became Chairman of BioAnaLab, subsequently acquired in 2009 by Millipore Corporation. He is Chairman of base4innovation, and a member from inception of the Bioscience Leadership Council.
    Paul Branthwaite A pharmacologist by training, Paul has operational and managerial experience within clinical development and medical affairs, including leading business development efforts and global clinical programmes for two CROs, and UK clinical operations for a Swedish biotech. Paul is a Senior Partner at TranScrip Partners and a member of the Management Team.
    Flic Gabbay Flic Gabbay is a pharmaceutical physician with over 25 years of industry experience, including as Global Head of Anti-infectives, at Parke Davis in the US. She has worked for pharma and bio-tech companies in Europe and North America. Flic is a co-founder of TranScrip Partners and is the Managing Partner.
    David Goldsmith David is a Consultant Kidney Physician at Guy's Hospital, Honorary Senior Lecturer, King's College and Deputy Director for Research and Development at Guy's and St Thomas NHS Foundation Trust, London. David is a Senior Partner at TranScrip Partners.
    Marcin Mankowski Marcin Mankowski is a pharmaceutical physician with 14 years experience in clinical development and medical affairs. Marcin worked for Bristol-Myers Squibb and later at Chiron Pharmaceuticals, where he was Head of Infectious Diseases in Europe. Marcin is a co-founder of TranScrip Partners and is the Operating Partner.
    N Sreeharan Dr Sreeharan (Sree) is a pharmaceutical physician with over 20 years industry experience. Before joining TranScrip Partners, Sree worked over 20 years at GlaxoSmithKline, where he held several Senior including that of Senior Vice President in the global R&D organization spanning over 20 years. Sree is a Senior Partner at TranScrip Partners and a member of the Management Team.